Recent content by urgentresearch

  1. urgentresearch

    Neurotec — Rosa Canina: Study-Backed Compound for Tinnitus Relief or a Scam?

    I apologize if I in any way derailed the thread with my quirky approach to joining this thread. @Furetto, I think you raised excellent questions and started this conversation in a way that deserved serious replies. Allow me to do that and move past my past messages. Here is part 1 of probably...
  2. urgentresearch

    Neurotec — Rosa Canina: Study-Backed Compound for Tinnitus Relief or a Scam?

    @Alberte, hi! Yes, we do have feedback from a number of early customers. We want to share it but there are a few reasons we are waiting. 1—the emails I get from subscribers/customers are private. I don't want people to wonder if any part of their communication is going to be used for some...
  3. urgentresearch

    Neurotec — Rosa Canina: Study-Backed Compound for Tinnitus Relief or a Scam?

    Friends, I have been following this thread since last Saturday—carefully reflecting on all the excellent points that have been brought up, and... more importantly, adding all of you dissenting voices to my "Enemies of the Treatment Report" list. Teasing, of course. (There is no such list—yet!)...
  4. urgentresearch

    Hough Ear Institute's Hair Cell Regeneration Project

    Something very, very strange about this NHPN-1010 story. I will share an update soon.
  5. urgentresearch

    Otonomy OTO-6XX — Hair Cell Regeneration

    I’m confused. Where did you hear this? Are you sure? My understanding is that Otonomy is the one making payments, as part of a licensing agreement. The agreement gives Otonomy exclusive rights to the patented compound (specifically for hearing loss). Otonomy pays cash up front plus milestone...
  6. urgentresearch

    Audion Therapeutics Trial

    We will not see a Phase 2b trial in the United States this year. As I said, this is a case study in propaganda and obfuscation. Phase 2b in U.S. this year = pure fantasy. When were the Phase 2 trial results supposed to be published or reported? How many times has that due date been pushed back...
  7. urgentresearch

    Audion Therapeutics Trial

    FYI AUD1001 (LY3056480) failed. Primary efficacy endpoints were not sufficiently met. But don't expect a big announcement from the companies or entities involved. Apparently it's a touchy subject... which requires layer upon layer of positive spin and reframing to avoid triggering any negative...
  8. urgentresearch

    My Posting Place

    The greatest tinnitus article of the last 2 decades was written over 7 years ago and has 0 citations.
  9. urgentresearch

    My Posting Place

    archaic design is best design
  10. urgentresearch

    My Posting Place

    It's funny because the technical term for this type of single cell organism learning is habituation :LOL: https://royalsocietypublishing.org/doi/10.1098/rspb.2016.0446 *starts timer to see how long it will take for someone to post in the ttalk research/treatment section asking HAS ANYONE TRY...
  11. urgentresearch

    Hough Ear Institute's Hair Cell Regeneration Project

    Thank you for the additional context, @Justin De Moss.
  12. urgentresearch

    My Posting Place

    Awesome
  13. urgentresearch

    My Posting Place

    It's quite fun